FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

Cold War Warning

Angela Merkel's successor has warned of the dangers of a…

Al Qaeda, ISIS could Pose Threat in 2 Years

Al Qaeda could pose a threat from Afghanistan to the U.S.…

Bennett: ‘Wake Up’ on Iran Nuke Deal

Israeli Prime Minister Naftali Bennet said the presidential…